16 June 2004
Can Levovist-enhanced Doppler ultrasound replace angiography in renal arteries imaging ?
Anna Drelich-Zbroja, Tomasz Jargiełło, Anna Szymańska, Wojciech Krzyżanowski, Małgorzata Szczerbo-TrojanowskaMed Sci Monit 2004; 10(3): 36-41 :: ID: 11872
Abstract
Background: To evaluate the diagnostic efficacy of ultrasound imaging of renal arteries after Levovist administration. Material/Methods: During a 20-month period, 100 hypertensive patients with suspected renal artery stenosis were referred to the Department of Interventional Radiology. In all patients, angiography and ultrasound examinations of renal arteries were performed (100 right, 100 left and 23 additional), before and after Levovist injection, using color and spectral Doppler. Results of Doppler examinations before and after Levovist administration were compared with results of angiography ('gold standard '). Hemodynamically significant renal artery stenoses (>50%in angiography)were diagnosed following Doppler parameters: Vmax >2 m/s, Vmin >1.5 m/s, RAR >3.5, acceleration time >0.08 s. Results: The diagnostic efficacy of Doppler examinations of the right renal artery (RRA)increased from 68% before to 98% after Levovist enhancement and diagnostic efficacy for the left renal artery (LRA) increased from 61% to 97%. In conventional study, 7 additional renal arteries (30.4%) were visualized, after Levovist administration this number increased to 15 (65.2%). Before Levovist injection, 3 stenoses of RRA and 1 stenosis of LRA were diagnosed. After Levovist enhancement, the number of RRA stenoses increased to 5 and that of LRA stenoses increased to 2, later confirmed by angiography. Conclusions: The use of Levovist increases the diagnostic efficacy of Doppler ultrasound examinations of renal arteries and makes it comparable to angiography.
Keywords: renal arteries, Doppler ultrasound, ultrasound contrast agents
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Clinical Research
Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum HypertrophyMed Sci Monit In Press; DOI: 10.12659/MSM.947508
Clinical Research
Balancing Image Quality and Iodine Intake: Insights from CT Spectral Imaging of the Portal VeinMed Sci Monit In Press; DOI: 10.12659/MSM.947391
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Most Viewed Current Articles
17 Jan 2024 : Review article 7,160,485
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,385
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,806
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,071
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912